Metastasis is responsible for 90 percent of cancer deaths. Researchers have found that the mutations driving it may stem from a commonly inherited variant of the PCSK9 gene. Metastasis is responsible ...
When the amount of cholesterol in the blood is too high, hypercholesterolemia can develop, causing serious damage to the arteries and cardiovascular health. Now, a study led by the University of ...
Verve Therapeutics Inc (NASDAQ:VERV) on Monday released initial data from the Heart-2 Phase 1b trial of VERVE-102 in patients with heterozygous familial hypercholesterolemia (HeFH) and/or premature ...
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics (VERV), a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced the clearance of ...
When the amount of cholesterol in the blood is too high, hypercholesterolemia can develop, causing serious damage to the arteries and cardiovascular health. Now, a study led by the University of ...
Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort ...
Add Yahoo as a preferred source to see more of our stories on Google. Christos Soteriou was 29 when he needed a quadruple bypass surgery. Four arteries in his heart had become so clogged with plaque ...
When mice are engineered to carry a variant of the human PCSK9 gene, they experience higher rates of breast cancer metastasis, as is apparent in these images of mouse lung tissue showing PCSK9’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results